Clinical Trials Directory

Trials / Completed

CompletedNCT02510677

Three-dimensional Assessment of Intraventricular Dyssynchrony Using Fast Dobutamine Gated SPECT

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The prognosis of patients with heart failure has improved due to recent breakthrough in medical treatment and cardiac resynchronization devices. However, there is no paraclinical parameter to assess response to cardiac resynchronization therapy (CRT). This is a major issue since about a third of implanted patients will not be improved by CRT. CZT SPECT allows to perform myocardial perfusion imaging in less than 4 minutes and is able to study myocardial perfusion, viability, left ventricular function, but also ventricular asynchrony. Using low-dose dobutamine gated SPECT and CZT camera, we aimed to assess left ventricular dyssynchrony in viable segments in patients with heart failure eligible for CRT.

Conditions

Interventions

TypeNameDescription
OTHERmyocardial perfusion scintigraphy

Timeline

Start date
2013-06-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2015-07-29
Last updated
2017-02-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02510677. Inclusion in this directory is not an endorsement.

Three-dimensional Assessment of Intraventricular Dyssynchrony Using Fast Dobutamine Gated SPECT (NCT02510677) · Clinical Trials Directory